Norditropin Simplexx


Indications and Reactions:

Role Indications Reactions
Primary
Growth Hormone Deficiency 42.2%
Drug Use For Unknown Indication 16.0%
Product Used For Unknown Indication 9.6%
Body Height Below Normal 7.5%
Small For Dates Baby 4.3%
Turner's Syndrome 4.3%
Hypopituitarism 3.7%
Growth Retardation 2.7%
Adrenogenital Syndrome 1.6%
Prader-willi Syndrome 1.6%
Blood Corticotrophin Abnormal 1.1%
Blood Follicle Stimulating Hormone Abnormal 1.1%
Adrenal Insufficiency 0.5%
Asthma 0.5%
Attention Deficit/hyperactivity Disorder 0.5%
Diabetes Insipidus 0.5%
Foetal Growth Retardation 0.5%
Hypochondroplasia 0.5%
Hypothyroidism 0.5%
Oestrogen Deficiency 0.5%
Sleep Apnoea Syndrome 7.3%
Vomiting 7.3%
Weight Decreased 7.3%
Anaphylactic Shock 5.5%
Chromosome Analysis Abnormal 5.5%
Convulsion 5.5%
Glomerulonephritis Proliferative 5.5%
Leukaemia Recurrent 5.5%
Osteonecrosis 5.5%
Urinary Bladder Polyp 5.5%
Wolff-parkinson-white Syndrome 5.5%
Wrist Fracture 5.5%
Blood Creatine Phosphokinase Increased 3.6%
Brain Scan Abnormal 3.6%
Death 3.6%
Developmental Glaucoma 3.6%
Disease Recurrence 3.6%
Germ Cell Cancer 3.6%
Hyperparathyroidism 3.6%
Hypotonia 3.6%
Secondary
Product Used For Unknown Indication 37.8%
Growth Hormone Deficiency 35.6%
Hypopituitarism 6.7%
Prader-willi Syndrome 6.7%
Small For Dates Baby 4.4%
Body Height Below Normal 2.2%
Diabetes Insipidus 2.2%
Foetal Growth Retardation 2.2%
Seasonal Allergy 2.2%
Germ Cell Cancer 14.3%
Sleep Apnoea Syndrome 9.5%
Astrocytoma 4.8%
Cellulitis 4.8%
Central Nervous System Lesion 4.8%
Convulsion 4.8%
Epilepsy 4.8%
Haemangioma-thrombocytopenia Syndrome 4.8%
Lipoma 4.8%
Medulloblastoma 4.8%
Nephrotic Syndrome 4.8%
Oedema Peripheral 4.8%
Papilloedema 4.8%
Peutz-jeghers Syndrome 4.8%
Precocious Puberty 4.8%
Somnolence 4.8%
Torticollis 4.8%
Tumour Marker Increased 4.8%

Drug Data